Press Releases Dangerous Proposal Would Exempt Rare Disease Drugs from FDA Randomized Trial Requirement November 7, 2024
Press Releases Patient, Research, and Provider Groups File Amicus Brief Supporting FDA’s Rule on Laboratory Developed Tests November 4, 2024
Fact Sheets & Backgrounders Impacts of Expanding and Lowering a Cap on Out-of-Pocket Drug Costs November 1, 2024
Outrage of the Month: The Continuing Influence of Industry Payments to U.S. Physicians November 1, 2024
Letters, Testimony & Filings Testimony Before the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee Regarding Sotagliflozin October 31, 2024
Press Releases Bavarian Nordic Mpox Shot Now Second-Most Expensive Vaccine UNICEF Distributes October 30, 2024